• Issue

    Journal of Viral Hepatitis: Volume 23, Issue 8

    i, 577-659
    August 2016
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Cover Image

Free Access

Cover Image

R. J. Harris,  N. K. Martin,  E. Rand,  S. Mandal,  D. Mutimer,  P. Vickerman,  M. E. Ramsay,  D. De Angelis,  M. Hickman,  H.E. Harris, 
  • Page: i
  • First Published: 19 July 2016
Cover Image

The cover image, by Helen E Harris et al., is based on the Original Article New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England, DOI: 10.1111/jvh.12529.

Issue Information

Free Access

Issue Information

  • Pages: 577-579
  • First Published: 19 July 2016

COMMENTARY

HCV encephalopathy – an artefact due to medical care?

K. Weissenborn,  H. L. Tillmann, 
  • Pages: 580-583
  • First Published: 26 May 2016

ORIGINAL ARTICLES

Is psychosocial and cognitive dysfunction misattributed to the virus in hepatitis C infection? Select psychosocial contributors identified

D. Lowry,  T. Burke,  Z. Galvin,  J. D. Ryan,  J. Russell,  A. Murphy,  J. Hegarty,  S. Stewart,  J. Crowe, 
  • Pages: 584-595
  • First Published: 11 May 2016

Matched population-based study examining the risk of type 2 diabetes in people with and without diagnosed hepatitis C virus infection

C. Schnier,  S. Wild,  Z. Kurdi,  C. Povey,  D. J. Goldberg,  S. J. Hutchinson, 
  • Pages: 596-605
  • First Published: 22 February 2016

Lymphomagenesis-related gene expression in B cells from sustained virological responders with occult hepatitis C virus infection

M. C. Roque Cuéllar,  J. R. García-Lozano,  B. Sánchez,  J. M. Praena-Fernández,  C. Martínez Sierra,  A. Núñez-Roldán,  J. Aguilar-Reina, 
  • Pages: 606-613
  • First Published: 04 March 2016
Open Access

GS-9857 in patients with chronic hepatitis C virus genotype 1–4 infection: a randomized, double-blind, dose-ranging phase 1 study

M. Rodriguez-Torres,  S. Glass,  J. Hill,  B. Freilich,  D. Hassman,  A. M. Di Bisceglie,  J. G. Taylor,  B. J. Kirby,  H. Dvory-Sobol,  J. C. Yang,  D. An,  L. M. Stamm,  D. M. Brainard,  S. Kim,  D. Krefetz,  W. Smith,  T. Marbury,  E. Lawitz, 
  • Pages: 614-622
  • First Published: 09 March 2016

Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus

Z. M. Younossi,  M. Stepanova,  L. Henry,  I. Younossi,  A. Weinstein,  F. Nader,  S. Hunt, 
  • Pages: 623-630
  • First Published: 14 March 2016
Open Access

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England

R. J. Harris,  N. K. Martin,  E. Rand,  S. Mandal,  D. Mutimer,  P. Vickerman,  M. E. Ramsay,  D. De Angelis,  M. Hickman,  H.E. Harris, 
  • Pages: 631-643
  • First Published: 29 March 2016

Antiviral response and resistance analysis of treatment-naïve HCV-infected patients receiving single and multiple doses of GS-9190

H. Mo,  C. Hedskog,  E. Svarovskaia,  S.-C. Sun,  I. M. Jacobson,  D. M. Brainard,  J. G. McHutchison,  M. D. Miller, 
  • Pages: 644-651
  • First Published: 23 March 2016

HLA-C and KIR combined genotype as new response marker for HBeAg-positive chronic hepatitis B patients treated with interferon-based combination therapy

F. Stelma,  L. Jansen,  M. J. Sinnige,  K. A. van Dort,  R. B. Takkenberg,  H. L. A. Janssen,  H. W. Reesink,  N. A. Kootstra, 
  • Pages: 652-659
  • First Published: 04 March 2016